nodes	percent_of_prediction	percent_of_DWPC	metapath
Isopropamide—Phenoxybenzamine—ADRA2C—attention deficit hyperactivity disorder	0.00965	0.35	CrCbGaD
Isopropamide—CHRM1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00629	0.00666	CbGpPWpGaD
Isopropamide—CHRM3—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00627	0.00664	CbGpPWpGaD
Isopropamide—CHRM3—Integration of energy metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00616	0.00652	CbGpPWpGaD
Isopropamide—CHRM3—Regulation of insulin secretion—CACNB2—attention deficit hyperactivity disorder	0.00541	0.00573	CbGpPWpGaD
Isopropamide—CHRM1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00524	0.00555	CbGpPWpGaD
Isopropamide—CHRM3—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00523	0.00553	CbGpPWpGaD
Isopropamide—Modafinil—SLC6A3—attention deficit hyperactivity disorder	0.00507	0.184	CrCbGaD
Isopropamide—CHRM3—Regulation of insulin secretion—CACNA1C—attention deficit hyperactivity disorder	0.00495	0.00524	CbGpPWpGaD
Isopropamide—CHRM4—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00478	0.00506	CbGpPWpGaD
Isopropamide—CHRM4—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00443	0.00469	CbGpPWpGaD
Isopropamide—CHRM1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00441	0.00466	CbGpPWpGaD
Isopropamide—Benzphetamine—SLC6A3—attention deficit hyperactivity disorder	0.00439	0.16	CrCbGaD
Isopropamide—CHRM3—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00439	0.00465	CbGpPWpGaD
Isopropamide—CHRM4—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00434	0.0046	CbGpPWpGaD
Isopropamide—CHRM4—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00434	0.0046	CbGpPWpGaD
Isopropamide—CHRM3—Regulation of insulin secretion—SNAP25—attention deficit hyperactivity disorder	0.00432	0.00458	CbGpPWpGaD
Isopropamide—CHRM4—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00431	0.00456	CbGpPWpGaD
Isopropamide—Benzphetamine—ADRA2A—attention deficit hyperactivity disorder	0.00431	0.156	CrCbGaD
Isopropamide—CHRM3—Integration of energy metabolism—CACNB2—attention deficit hyperactivity disorder	0.00425	0.0045	CbGpPWpGaD
Isopropamide—CHRM3—Regulation of insulin secretion—ADRA2A—attention deficit hyperactivity disorder	0.00412	0.00436	CbGpPWpGaD
Isopropamide—Phenoxybenzamine—ADRA2A—attention deficit hyperactivity disorder	0.00412	0.149	CrCbGaD
Isopropamide—CHRM3—Integration of energy metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00389	0.00412	CbGpPWpGaD
Isopropamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0038	0.00402	CbGpPWpGaD
Isopropamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00372	0.00394	CbGpPWpGaD
Isopropamide—CHRM3—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00366	0.00388	CbGpPWpGaD
Isopropamide—CHRM4—nervous system—attention deficit hyperactivity disorder	0.0036	0.13	CbGeAlD
Isopropamide—CHRM3—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00356	0.00377	CbGpPWpGaD
Isopropamide—CHRM4—central nervous system—attention deficit hyperactivity disorder	0.00346	0.125	CbGeAlD
Isopropamide—CHRM3—Integration of energy metabolism—SNAP25—attention deficit hyperactivity disorder	0.0034	0.0036	CbGpPWpGaD
Isopropamide—CHRM4—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00324	0.00343	CbGpPWpGaD
Isopropamide—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00324	0.117	CbGeAlD
Isopropamide—CHRM3—Integration of energy metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00324	0.00343	CbGpPWpGaD
Isopropamide—CHRM4—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00301	0.00319	CbGpPWpGaD
Isopropamide—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00299	0.00316	CbGpPWpGaD
Isopropamide—CHRM3—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00298	0.00315	CbGpPWpGaD
Isopropamide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00293	0.0031	CbGpPWpGaD
Isopropamide—CHRM1—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00293	0.0031	CbGpPWpGaD
Isopropamide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00292	0.00309	CbGpPWpGaD
Isopropamide—CHRM3—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00292	0.00309	CbGpPWpGaD
Isopropamide—CHRM1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00291	0.00308	CbGpPWpGaD
Isopropamide—CHRM3—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0029	0.00307	CbGpPWpGaD
Isopropamide—CHRM3—forebrain—attention deficit hyperactivity disorder	0.0029	0.104	CbGeAlD
Isopropamide—CHRM4—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00289	0.00306	CbGpPWpGaD
Isopropamide—CHRM4—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00283	0.003	CbGpPWpGaD
Isopropamide—CHRM4—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00283	0.003	CbGpPWpGaD
Isopropamide—CHRM4—brain—attention deficit hyperactivity disorder	0.00275	0.099	CbGeAlD
Isopropamide—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.00274	0.0986	CbGeAlD
Isopropamide—CHRM4—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00263	0.00278	CbGpPWpGaD
Isopropamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00258	0.00273	CbGpPWpGaD
Isopropamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00256	0.00271	CbGpPWpGaD
Isopropamide—CHRM4—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00255	0.0027	CbGpPWpGaD
Isopropamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00255	0.0027	CbGpPWpGaD
Isopropamide—CHRM1—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.00252	0.00267	CbGpPWpGaD
Isopropamide—CHRM4—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00251	0.00266	CbGpPWpGaD
Isopropamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00251	0.00266	CbGpPWpGaD
Isopropamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0025	0.00265	CbGpPWpGaD
Isopropamide—CHRM4—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00248	0.00262	CbGpPWpGaD
Isopropamide—CHRM4—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00245	0.00259	CbGpPWpGaD
Isopropamide—CHRM4—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00244	0.00258	CbGpPWpGaD
Isopropamide—CHRM4—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00237	0.00251	CbGpPWpGaD
Isopropamide—CHRM4—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00233	0.00246	CbGpPWpGaD
Isopropamide—CHRM3—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00232	0.00246	CbGpPWpGaD
Isopropamide—CHRM4—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00231	0.00244	CbGpPWpGaD
Isopropamide—CHRM4—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.0023	0.00243	CbGpPWpGaD
Isopropamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00225	0.00239	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00221	0.00234	CbGpPWpGaD
Isopropamide—CHRM4—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00214	0.00227	CbGpPWpGaD
Isopropamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0021	0.00222	CbGpPWpGaD
Isopropamide—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00203	0.00215	CbGpPWpGaD
Isopropamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00203	0.00215	CbGpPWpGaD
Isopropamide—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00202	0.00214	CbGpPWpGaD
Isopropamide—CHRM1—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00201	0.00213	CbGpPWpGaD
Isopropamide—CHRM1—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00201	0.00213	CbGpPWpGaD
Isopropamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00199	0.00211	CbGpPWpGaD
Isopropamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00197	0.00209	CbGpPWpGaD
Isopropamide—CHRM4—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00196	0.00208	CbGpPWpGaD
Isopropamide—CHRM1—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00195	0.00206	CbGpPWpGaD
Isopropamide—CHRM1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00195	0.00206	CbGpPWpGaD
Isopropamide—CHRM3—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00194	0.00206	CbGpPWpGaD
Isopropamide—CHRM1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00191	0.00202	CbGpPWpGaD
Isopropamide—CHRM3—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.0019	0.00202	CbGpPWpGaD
Isopropamide—CHRM1—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00189	0.002	CbGpPWpGaD
Isopropamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00184	0.00194	CbGpPWpGaD
Isopropamide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00177	0.00188	CbGpPWpGaD
Isopropamide—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00177	0.00187	CbGpPWpGaD
Isopropamide—CHRM1—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00176	0.00187	CbGpPWpGaD
Isopropamide—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00176	0.0633	CbGeAlD
Isopropamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00174	0.00184	CbGpPWpGaD
Isopropamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00173	0.00183	CbGpPWpGaD
Isopropamide—CHRM4—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00172	0.00182	CbGpPWpGaD
Isopropamide—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00169	0.0609	CbGeAlD
Isopropamide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00165	0.00175	CbGpPWpGaD
Isopropamide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00164	0.00174	CbGpPWpGaD
Isopropamide—CHRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00164	0.00174	CbGpPWpGaD
Isopropamide—CHRM3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00164	0.00173	CbGpPWpGaD
Isopropamide—CHRM4—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00163	0.00173	CbGpPWpGaD
Isopropamide—CHRM4—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.0016	0.00169	CbGpPWpGaD
Isopropamide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.0016	0.00169	CbGpPWpGaD
Isopropamide—CHRM4—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0016	0.00169	CbGpPWpGaD
Isopropamide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00159	0.00169	CbGpPWpGaD
Isopropamide—CHRM3—nervous system—attention deficit hyperactivity disorder	0.00157	0.0566	CbGeAlD
Isopropamide—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00157	0.00166	CbGpPWpGaD
Isopropamide—CHRM3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00156	0.00166	CbGpPWpGaD
Isopropamide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00155	0.00164	CbGpPWpGaD
Isopropamide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00155	0.00164	CbGpPWpGaD
Isopropamide—CHRM4—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00155	0.00164	CbGpPWpGaD
Isopropamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00152	0.00161	CbGpPWpGaD
Isopropamide—CHRM4—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00152	0.00161	CbGpPWpGaD
Isopropamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00151	0.0016	CbGpPWpGaD
Isopropamide—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00151	0.0545	CbGeAlD
Isopropamide—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.0015	0.00159	CbGpPWpGaD
Isopropamide—CHRM4—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0015	0.00159	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00149	0.00158	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00149	0.00157	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00148	0.00157	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00145	0.00154	CbGpPWpGaD
Isopropamide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00144	0.00153	CbGpPWpGaD
Isopropamide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00144	0.00152	CbGpPWpGaD
Isopropamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00141	0.0015	CbGpPWpGaD
Isopropamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00141	0.00149	CbGpPWpGaD
Isopropamide—CHRM4—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.0014	0.00148	CbGpPWpGaD
Isopropamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00137	0.00145	CbGpPWpGaD
Isopropamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00136	0.00144	CbGpPWpGaD
Isopropamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00135	0.00142	CbGpPWpGaD
Isopropamide—CHRM1—brain—attention deficit hyperactivity disorder	0.00134	0.0484	CbGeAlD
Isopropamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00134	0.00142	CbGpPWpGaD
Isopropamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00133	0.00141	CbGpPWpGaD
Isopropamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00132	0.0014	CbGpPWpGaD
Isopropamide—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00132	0.0014	CbGpPWpGaD
Isopropamide—CHRM3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00132	0.0014	CbGpPWpGaD
Isopropamide—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00131	0.00139	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00131	0.00138	CbGpPWpGaD
Isopropamide—CHRM3—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.0013	0.00138	CbGpPWpGaD
Isopropamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00129	0.00136	CbGpPWpGaD
Isopropamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00124	0.00131	CbGpPWpGaD
Isopropamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00123	0.00131	CbGpPWpGaD
Isopropamide—CHRM3—brain—attention deficit hyperactivity disorder	0.0012	0.0433	CbGeAlD
Isopropamide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00117	0.00124	CbGpPWpGaD
Isopropamide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00117	0.00124	CbGpPWpGaD
Isopropamide—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00116	0.00123	CbGpPWpGaD
Isopropamide—CHRM3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00115	0.00122	CbGpPWpGaD
Isopropamide—CHRM4—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00111	0.00117	CbGpPWpGaD
Isopropamide—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0011	0.00117	CbGpPWpGaD
Isopropamide—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0011	0.00116	CbGpPWpGaD
Isopropamide—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00108	0.00114	CbGpPWpGaD
Isopropamide—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00108	0.00114	CbGpPWpGaD
Isopropamide—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00108	0.00114	CbGpPWpGaD
Isopropamide—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00107	0.00114	CbGpPWpGaD
Isopropamide—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00104	0.0011	CbGpPWpGaD
Isopropamide—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00104	0.0011	CbGpPWpGaD
Isopropamide—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00102	0.00108	CbGpPWpGaD
Isopropamide—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00102	0.00108	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00102	0.00108	CbGpPWpGaD
Isopropamide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00101	0.00107	CbGpPWpGaD
Isopropamide—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00101	0.00107	CbGpPWpGaD
Isopropamide—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00101	0.00107	CbGpPWpGaD
Isopropamide—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00101	0.00107	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00101	0.00107	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.001	0.00106	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000997	0.00106	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00098	0.00104	CbGpPWpGaD
Isopropamide—CHRM4—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000979	0.00104	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000977	0.00103	CbGpPWpGaD
Isopropamide—CHRM4—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00097	0.00103	CbGpPWpGaD
Isopropamide—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000942	0.000998	CbGpPWpGaD
Isopropamide—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000939	0.000994	CbGpPWpGaD
Isopropamide—CHRM4—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000902	0.000955	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000881	0.000933	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000881	0.000932	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000879	0.00093	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000877	0.000928	CbGpPWpGaD
Isopropamide—CHRM4—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000873	0.000924	CbGpPWpGaD
Isopropamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000867	0.000917	CbGpPWpGaD
Isopropamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000864	0.000915	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000859	0.000909	CbGpPWpGaD
Isopropamide—CHRM4—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000858	0.000909	CbGpPWpGaD
Isopropamide—CHRM4—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000848	0.000897	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000842	0.000892	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000819	0.000867	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000793	0.00084	CbGpPWpGaD
Isopropamide—CHRM4—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00079	0.000836	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00078	0.000825	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00077	0.000815	CbGpPWpGaD
Isopropamide—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000748	0.000792	CbGpPWpGaD
Isopropamide—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000746	0.00079	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000717	0.000759	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000705	0.000746	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000688	0.000728	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000686	0.000726	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00068	0.000719	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000677	0.000717	CbGpPWpGaD
Isopropamide—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00066	0.000699	CbGpPWpGaD
Isopropamide—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000658	0.000696	CbGpPWpGaD
Isopropamide—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000654	0.000693	CbGpPWpGaD
Isopropamide—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000654	0.000692	CbGpPWpGaD
Isopropamide—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000652	0.00069	CbGpPWpGaD
Isopropamide—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000608	0.000644	CbGpPWpGaD
Isopropamide—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000606	0.000642	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000595	0.00063	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000594	0.000629	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000592	0.000627	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000591	0.000626	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000589	0.000624	CbGpPWpGaD
Isopropamide—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000589	0.000623	CbGpPWpGaD
Isopropamide—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000587	0.000621	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000579	0.000613	CbGpPWpGaD
Isopropamide—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000579	0.000613	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000577	0.000611	CbGpPWpGaD
Isopropamide—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000577	0.000611	CbGpPWpGaD
Isopropamide—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000572	0.000605	CbGpPWpGaD
Isopropamide—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00057	0.000603	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000568	0.000601	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000566	0.000599	CbGpPWpGaD
Isopropamide—CHRM4—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000553	0.000586	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000552	0.000584	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00055	0.000583	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000535	0.000566	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000533	0.000564	CbGpPWpGaD
Isopropamide—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000533	0.000564	CbGpPWpGaD
Isopropamide—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000531	0.000562	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000526	0.000556	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000524	0.000555	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00052	0.000551	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000519	0.00055	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000517	0.000548	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000502	0.000532	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000486	0.000515	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000486	0.000515	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000484	0.000512	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000484	0.000512	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000482	0.00051	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000479	0.000507	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000469	0.000496	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000461	0.000487	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000455	0.000481	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000445	0.000471	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000424	0.000449	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000401	0.000425	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.0004	0.000424	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000389	0.000412	CbGpPWpGaD
Isopropamide—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000373	0.000395	CbGpPWpGaD
Isopropamide—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000372	0.000394	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00037	0.000392	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000351	0.000371	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00035	0.00037	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000339	0.000359	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000338	0.000357	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000326	0.000345	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000325	0.000344	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000316	0.000334	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000315	0.000333	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000311	0.000329	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00031	0.000328	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000307	0.000325	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000306	0.000324	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000297	0.000314	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000295	0.000312	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000293	0.00031	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000286	0.000302	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000285	0.000301	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.0002	0.000212	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000199	0.000211	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000157	0.000166	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	0.000126	0.000134	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000106	0.000112	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000106	0.000112	CbGpPWpGaD
